Home / Business and Economy / CEO Sells $34.6M in Stock, Retains Majority Stake
CEO Sells $34.6M in Stock, Retains Majority Stake
23 Jul
Summary
- CEO John Oyler sold 109,713 shares worth $34.6 million.
- The sale occurred under a pre-arranged trading plan.
- Oyler retains over 50.4 million total shares post-transaction.
John Oyler, CEO of BeOne Medicines AG, divested 109,713 American Depositary Shares in late July 2026. The transactions, which took place on July 20 and 21, were executed under a pre-established Rule 10b5-1 trading plan adopted earlier in the year. This plan allows company insiders to schedule stock sales in advance.
Despite the sale realizing approximately $34.6 million, Oyler continues to hold a dominant position in the company. His total shareholding remains over 50.4 million, reflecting a strong capital commitment. The weighted average sale price of $315.28 per share was achieved after the stock experienced a 9% return in the preceding year.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
